OssDsign AB Logo

OssDsign AB

Developer of orthobiologics for bone regeneration in spinal fusion surgery.

OSSD | ST

Overview

Corporate Details

ISIN(s):
SE0012570448
LEI:
5493005SNS5NAYE2WL53
Country:
Sweden
Address:
Ulls väg 29C, 756 51 Uppsala

Description

OssDsign is a developer and global provider of next-generation orthobiologics products based on advanced material science. The company develops and markets products that support the body's own healing capabilities, with a primary focus on bone regeneration for spinal fusion surgery. Its flagship product, OssDsign Catalyst®, is a nanosynthetic bone graft putty engineered to engage dual bone formation pathways, promoting rapid and reliable bone formation. OssDsign Catalyst® is the first synthetic bone graft to receive clearance for on-label interbody use based on bone graft data alone, allowing it to be used in any interbody cage cleared for use with synthetic bone grafts. This unique regulatory status, combined with its handling characteristics, differentiates the product in the orthobiologics market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all OssDsign AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OssDsign AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OssDsign AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Camp4 Therapeutics Corp Logo
Develops RNA-based therapeutics to amplify protein expression for genetic diseases.
United States of America
CAMP
Camurus Logo
Develops and commercializes long-acting medicines for severe and chronic diseases.
Sweden
CAMX
Candel Therapeutics, Inc. Logo
Develops viral immunotherapies to activate the immune system to fight cancer.
United States of America
CADL
Can-Fite BioPharma Ltd. Logo
Clinical-stage biopharma developing oral small-molecule drugs targeting the A3AR.
Israel
CANF
Cannabotech Ltd. Logo
Develops therapies by integrating cannabinoids and medicinal mushroom extracts.
Israel
CNTC
Cannovum Cannabis AG Logo
Licensed importer, wholesaler, and manufacturer of medical cannabis products.
Germany
27N0
Cantargia Logo
Develops antibody therapies targeting IL1RAP for cancer and inflammatory diseases.
Sweden
CANTA
Cantourage Group SE Logo
Produces and distributes EU-compliant medical cannabis from international partners.
Germany
HIGH
CAPRICOR THERAPEUTICS, INC. Logo
A clinical-stage biotech developing cell and exosome-based biologics for serious diseases.
United States of America
CAPR
A clinical-stage biotech developing regenerative medicines for heart failure.
United Kingdom
N/A

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.